Feedback / Questions
CER-1236 - CERo Therap
https://www.globenewswire.com/news-release/2025/06/17/3100623/0/en/CERo-Therapeutics-Holdings-Inc-Announces-FDA-Orphan-Drug-Designation-Granted-to-CER-1236-for-the-Treatment-of-Acute-Myeloid-Leukemia-AML.html
Jun 17, 2025
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Next